CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
ferumoxytoldrug
Likely dose
ferumoxytol 1020 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01374919
NCT01374919N/ACompleted
CompareCT.gov

Total Dose Infusion of Ferumoxytol (1020mg) in 15 Minutes for Iron Defeciency Anemia

Auerbach Hematology Oncology Associates P C·interventional·Posted Jun 16, 2011·Updated Oct 15, 2025

In Brief

A clinical study evaluating ferumoxytol for Iron Deficiency Anemia. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The aim of the study is to recruit 30 patients who have been referred to Auerach Hematology Oncology Assoc. for the treatment of iron defeciency anemia with iv iron (Ferumoxytol 1020 mg) administered via infusion pump over 15 minutes. To ascertain acute safety and tolerability of ferumoxytol during immediate post dosing observation period. Assess additional safety profile and laboratory assessment at follow up visit and interim telephone follow up.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIron Deficiency Anemia
CountriesUnited States
CollaboratorsAMAG Pharmaceuticals, Inc.

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJun 16, 2011
Enrollment StartJun 1, 2011
Primary CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 15.0 years ago

Interventions

ferumoxytoldrug

IV administration of 1020 mg of ferumoxytol in 15 minutes